O	0	1	A
O	2	12	randomized
O	13	18	trial
O	19	21	of
B-intervention	22	35	interpersonal
I-intervention	36	49	psychotherapy
I-intervention	49	50	,
I-intervention	51	58	problem
I-intervention	59	66	solving
I-intervention	67	74	therapy
I-intervention	74	75	,
I-intervention	76	79	and
I-intervention	80	90	supportive
I-intervention	91	98	therapy
O	99	102	for
B-condition	103	108	major
I-condition	109	119	depressive
I-condition	120	128	disorder
O	129	131	in
O	132	137	women
O	138	142	with
O	143	149	breast
O	150	156	cancer
O	156	157	.

O	158	164	Breast
O	165	171	cancer
O	172	173	(
O	173	175	BC
O	175	176	)
O	177	179	is
O	180	181	a
O	182	186	risk
O	187	193	factor
O	194	197	for
O	198	203	major
O	204	214	depressive
O	215	223	disorder
O	224	225	(
O	225	228	MDD
O	228	229	)
O	229	230	,
O	231	234	yet
O	235	241	little
O	242	250	research
O	251	254	has
O	255	261	tested
O	262	265	the
O	266	274	efficacy
O	275	277	of
O	278	287	different
O	288	303	psychotherapies
O	304	307	for
O	308	317	depressed
O	318	323	women
O	324	328	with
O	329	331	BC
O	331	332	.

O	333	337	This
O	338	343	study
O	343	344	,
O	345	348	the
O	349	356	largest
O	357	359	to
O	360	364	date
O	364	365	,
O	366	374	compared
O	375	383	outcomes
O	384	386	of
O	387	392	three
O	393	401	evidence
O	401	402	-
O	402	407	based
O	407	408	,
O	409	411	12
O	411	412	-
O	412	416	week
O	417	426	therapies
O	427	429	in
O	430	438	treating
O	439	444	major
O	445	455	depressive
O	456	464	disorder
O	465	470	among
O	471	476	women
O	477	481	with
O	482	488	breast
O	489	495	cancer
O	495	496	.

O	497	501	This
O	502	512	randomized
O	513	518	trial
O	519	527	compared
O	528	541	interpersonal
O	542	555	psychotherapy
O	556	557	(
O	557	560	IPT
O	560	561	)
O	561	562	,
O	563	570	problem
O	571	578	solving
O	579	586	therapy
O	587	588	(
O	588	591	PST
O	591	592	)
O	592	593	,
O	594	597	and
O	598	603	brief
O	604	614	supportive
O	615	628	psychotherapy
O	629	630	(
O	630	633	BSP
O	633	634	)
O	634	635	.

O	636	645	Conducted
O	646	648	at
O	649	652	the
O	653	663	outpatient
O	664	670	clinic
O	671	673	of
O	674	677	the
B-location	678	681	New
I-location	682	686	York
I-location	687	692	State
O	693	704	Psychiatric
O	705	714	Institute
O	714	715	/
O	715	723	Columbia
O	724	734	University
O	734	735	,
O	736	739	the
O	740	745	trial
O	746	753	offered
O	754	763	bilingual
O	764	773	treatment
O	774	776	by
O	777	786	treatment
O	786	787	-
O	787	795	specific
O	796	812	psychotherapists
O	813	823	supervised
O	824	826	by
O	827	836	treatment
O	837	844	experts
O	844	845	.

O	846	849	The
O	850	857	primary
O	858	865	outcome
O	866	869	was
B-outcome-Measure	870	876	change
I-outcome-Measure	877	879	in
I-outcome-Measure	880	883	the
I-outcome-Measure	884	892	Hamilton
I-outcome-Measure	893	903	Depression
I-outcome-Measure	904	910	Rating
I-outcome-Measure	911	916	Scale
I-outcome-Measure	917	918	(
I-outcome-Measure	918	921	HAM
I-outcome-Measure	921	922	-
I-outcome-Measure	922	923	D
I-outcome-Measure	923	924	)
I-outcome-Measure	925	927	at
I-outcome-Measure	928	930	12
I-outcome-Measure	931	936	weeks
O	936	937	.

O	938	947	Secondary
O	948	956	outcomes
O	957	965	included
B-outcome-Measure	966	971	other
I-outcome-Measure	972	981	validated
I-outcome-Measure	982	989	patient
I-outcome-Measure	989	990	-
I-outcome-Measure	990	998	reported
I-outcome-Measure	999	1007	outcomes
I-outcome-Measure	1008	1011	for
I-outcome-Measure	1012	1022	depression
I-outcome-Measure	1023	1026	and
I-outcome-Measure	1027	1034	quality
I-outcome-Measure	1035	1037	of
I-outcome-Measure	1038	1042	life
O	1042	1043	.

O	1044	1046	Of
B-total-participants	1047	1050	179
B-eligibility	1051	1056	women
I-eligibility	1057	1061	with
I-eligibility	1062	1068	breast
I-eligibility	1069	1075	cancer
I-eligibility	1076	1085	screening
I-eligibility	1086	1094	positive
I-eligibility	1095	1098	for
I-eligibility	1099	1109	depression
O	1110	1112	at
O	1113	1116	the
O	1117	1125	Columbia
O	1126	1132	Cancer
O	1133	1139	Center
O	1139	1140	,
B-total-participants	1141	1144	134
O	1145	1153	eligible
O	1154	1162	patients
O	1163	1169	signed
O	1170	1178	informed
O	1179	1188	treatment
O	1189	1196	consent
O	1196	1197	.

O	1198	1202	Half
O	1203	1205	of
O	1206	1214	patients
O	1215	1219	were
B-ethinicity	1220	1228	Hispanic
O	1229	1232	and
O	1233	1245	economically
O	1246	1259	disadvantaged
O	1259	1260	.

O	1261	1265	Most
O	1266	1271	women
O	1272	1275	had
O	1276	1281	stage
O	1282	1283	I
O	1284	1285	(
O	1285	1287	35
O	1287	1288	.
O	1288	1289	2
O	1289	1290	%
O	1290	1291	)
O	1292	1294	or
O	1295	1297	II
O	1298	1299	(
O	1299	1301	36
O	1301	1302	.
O	1302	1303	9
O	1303	1304	%
O	1304	1305	)
O	1306	1308	BC
O	1308	1309	;
O	1310	1311	9
O	1311	1312	%
O	1313	1316	had
O	1317	1322	stage
O	1323	1325	IV
O	1325	1326	.

O	1327	1330	The
O	1331	1336	three
O	1337	1342	brief
O	1343	1358	psychotherapies
O	1359	1365	showed
O	1366	1373	similar
B-outcome	1374	1386	improvements
I-outcome	1387	1389	on
I-outcome	1390	1393	the
I-outcome	1394	1397	HAM
I-outcome	1397	1398	-
I-outcome	1398	1399	D
O	1399	1400	,
O	1401	1405	with
O	1406	1411	large
O	1412	1415	pre
O	1415	1416	-
O	1416	1420	post
O	1421	1427	effect
O	1428	1433	sizes
O	1434	1435	(
O	1435	1436	d
O	1437	1438	~
O	1439	1440	1
O	1440	1441	.
O	1441	1442	0
O	1442	1443	)
O	1443	1444	;
O	1445	1446	a
O	1447	1453	priori
O	1454	1461	defined
B-outcome	1462	1470	response
I-outcome	1471	1476	rates
O	1477	1481	were
B-iv-bin-percent	1482	1484	35
I-iv-bin-percent	1484	1485	%
O	1486	1489	for
O	1490	1493	IPT
O	1493	1494	,
B-iv-bin-percent	1495	1497	50
I-iv-bin-percent	1497	1498	%
O	1499	1502	for
O	1503	1506	PST
O	1507	1510	and
B-iv-bin-percent	1511	1513	31
I-iv-bin-percent	1513	1514	%
O	1515	1518	for
O	1519	1522	BSP
O	1522	1523	,
O	1524	1527	and
B-outcome	1528	1537	remission
I-outcome	1538	1543	rates
B-iv-bin-percent	1544	1546	25
I-iv-bin-percent	1546	1547	%
O	1547	1548	,
B-iv-bin-percent	1549	1551	30
I-iv-bin-percent	1551	1552	%
O	1553	1556	and
B-iv-bin-percent	1557	1559	27
I-iv-bin-percent	1559	1560	%
O	1560	1561	,
O	1562	1574	respectively
O	1574	1575	.

O	1576	1579	The
O	1580	1585	three
O	1586	1596	treatments
O	1597	1601	also
O	1602	1608	showed
O	1609	1616	similar
O	1617	1629	improvements
O	1630	1632	in
O	1633	1636	the
B-outcome	1637	1644	Quality
I-outcome	1645	1647	of
I-outcome	1648	1652	Life
I-outcome	1653	1662	Enjoyment
I-outcome	1663	1666	and
I-outcome	1667	1679	Satisfaction
I-outcome	1680	1693	Questionnaire
O	1693	1694	.

B-outcome	1695	1702	Dropout
O	1703	1706	was
O	1707	1711	high
O	1711	1712	,
O	1713	1720	ranging
O	1721	1725	from
O	1726	1728	37
O	1729	1731	to
O	1732	1734	52
O	1734	1735	%
O	1736	1742	across
O	1743	1753	treatments
O	1753	1754	.

O	1755	1765	Predictors
O	1766	1768	of
O	1769	1776	dropout
O	1777	1785	included
O	1786	1792	having
O	1793	1794	<
O	1795	1797	16
O	1798	1803	years
O	1804	1806	of
O	1807	1816	education
O	1817	1820	and
O	1821	1827	annual
O	1828	1834	family
O	1835	1841	income
O	1842	1843	<
O	1844	1845	$
O	1845	1847	20
O	1847	1848	,
O	1848	1851	000
O	1851	1852	.

O	1853	1858	Among
O	1859	1867	patients
O	1868	1871	who
O	1872	1881	completed
O	1882	1891	treatment
O	1891	1892	,
O	1893	1896	all
O	1897	1902	three
O	1903	1918	psychotherapies
O	1919	1923	were
O	1924	1934	associated
O	1935	1939	with
O	1940	1947	similar
O	1947	1948	,
O	1949	1959	meaningful
O	1960	1972	improvements
O	1973	1975	in
O	1976	1986	depression
O	1986	1987	.

O	1988	1996	Physical
O	1997	2005	distance
O	2006	2013	between
O	2014	2017	the
O	2018	2026	oncology
O	2027	2030	and
O	2031	2042	psychiatric
O	2043	2052	treatment
O	2053	2058	sites
O	2059	2064	might
O	2065	2069	have
O	2070	2081	contributed
O	2082	2084	to
O	2085	2089	high
O	2090	2097	dropout
O	2097	2098	.

O	2099	2103	This
O	2104	2109	study
O	2110	2118	suggests
O	2119	2126	various
O	2127	2140	psychotherapy
O	2141	2151	approaches
O	2152	2155	may
O	2156	2163	benefit
O	2164	2172	patients
O	2173	2177	with
O	2178	2184	breast
O	2185	2191	cancer
O	2192	2195	and
O	2196	2201	major
O	2202	2212	depression
O	2212	2213	.
